Regen BioPharma Inc (RGBP)
0.58
+0.02
(+3.57%)
USD |
OTCM |
May 10, 11:56
Regen BioPharma Total Liabilities (Quarterly): 5.317M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.317M |
| December 31, 2023 | 5.401M |
| September 30, 2023 | 5.458M |
| June 30, 2023 | 5.314M |
| February 28, 2023 | 5.336M |
| December 31, 2022 | 5.299M |
| September 30, 2022 | 8.595M |
| June 30, 2022 | 9.039M |
| March 31, 2022 | 77.38M |
| December 31, 2021 | 10.49M |
| September 30, 2021 | 14.70M |
| June 30, 2021 | 11.97M |
| March 31, 2021 | 5.249M |
| December 31, 2020 | 5.732M |
| September 30, 2020 | 7.458M |
| June 30, 2020 | 8.654M |
| March 31, 2020 | 11.84M |
| December 31, 2019 | 7.740M |
| September 30, 2019 | 11.01M |
| June 30, 2019 | 12.90M |
| March 31, 2019 | 8.866M |
| Date | Value |
|---|---|
| December 31, 2018 | 8.846M |
| September 30, 2018 | 9.331M |
| June 30, 2018 | 9.134M |
| March 31, 2018 | 9.594M |
| December 31, 2017 | 8.950M |
| September 30, 2017 | 6.196M |
| June 30, 2017 | 4.984M |
| March 31, 2017 | 2.062M |
| December 31, 2016 | 0.8628M |
| September 30, 2016 | 0.9063M |
| June 30, 2016 | 0.7521M |
| March 31, 2016 | 0.4483M |
| December 31, 2015 | 0.3402M |
| September 30, 2015 | 0.3176M |
| June 30, 2015 | 0.1453M |
| March 31, 2015 | 0.1801M |
| December 31, 2014 | 0.3259M |
| September 30, 2014 | 0.1403M |
| June 30, 2014 | 0.0575M |
| March 31, 2014 | 0.0076M |
| September 30, 2013 | 0.00 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.249M
Minimum
Mar 2021
77.38M
Maximum
Mar 2022
11.74M
Average
8.168M
Median
Total Liabilities (Quarterly) Benchmarks
| CervoMed Inc | 2.596M |
| GlucoTrack Inc | 1.708M |
| AIM ImmunoTech Inc | 9.147M |
| Protalix BioTherapeutics Inc | 50.86M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.1408M |
| Shareholders Equity (Quarterly) | -5.176M |
| Debt to Equity Ratio | -0.134 |
| Current Ratio | 0.0238 |
| Net Debt Paydown Yield | -1.18% |